Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasis (Q36691482)

From Wikidata
Jump to navigation Jump to search
scientific article published on 27 March 2008
edit
Language Label Description Also known as
English
Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasis
scientific article published on 27 March 2008

    Statements

    Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasis (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit